<code id='69A113420D'></code><style id='69A113420D'></style>
    • <acronym id='69A113420D'></acronym>
      <center id='69A113420D'><center id='69A113420D'><tfoot id='69A113420D'></tfoot></center><abbr id='69A113420D'><dir id='69A113420D'><tfoot id='69A113420D'></tfoot><noframes id='69A113420D'>

    • <optgroup id='69A113420D'><strike id='69A113420D'><sup id='69A113420D'></sup></strike><code id='69A113420D'></code></optgroup>
        1. <b id='69A113420D'><label id='69A113420D'><select id='69A113420D'><dt id='69A113420D'><span id='69A113420D'></span></dt></select></label></b><u id='69A113420D'></u>
          <i id='69A113420D'><strike id='69A113420D'><tt id='69A113420D'><pre id='69A113420D'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:973
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          President Biden's budget: Here's what you might have missed
          President Biden's budget: Here's what you might have missed

          PresidentBidenspeaksatacampaigneventinAtlantathismonth.MeganVarner/GettyImagesWASHINGTON—PresidentBi

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand